Skip to Content

Chiome Bioscience Inc 4583

Morningstar Rating
JPY 143.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4583 is trading at a 38% discount.
Price
JPY 145.04
Fair Value
JPY 287.76
Uncertainty
Extreme
1-Star Price
JPY 9,928.33
5-Star Price
JPY 36.94
Economic Moat
Xyhx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4583 is a good fit for your portfolio.

Trading Information

Previous Close Price
JPY 143.00
Day Range
JPY 141.00144.00
52-Week Range
JPY 117.00261.00
Bid/Ask
JPY 142.00 / JPY 143.00
Market Cap
JPY 7.53 Bil
Volume/Avg
329,100 / 824,537

Key Statistics

Price/Earnings (Normalized)
Price/Sales
10.38
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
63

Comparables

Valuation

Metric
4583
4893
4565
Price/Earnings (Normalized)
36.26
Price/Book Value
6.501.332.14
Price/Sales
10.3823.3110.35
Price/Cash Flow
Price/Earnings
4583
4893
4565

Financial Strength

Metric
4583
4893
4565
Quick Ratio
2.6630.723.29
Current Ratio
3.0231.073.79
Interest Coverage
−586.25−3.82
Quick Ratio
4583
4893
4565

Profitability

Metric
4583
4893
4565
Return on Assets (Normalized)
−64.36%−23.29%−4.62%
Return on Equity (Normalized)
−88.97%−24.23%−9.26%
Return on Invested Capital (Normalized)
−73.89%−24.24%−4.48%
Return on Assets
4583
4893
4565
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRDpvrmgldlRnpy$571.0 Bil
VRTX
Vertex Pharmaceuticals IncYpcnxgffFnkxj$107.8 Bil
REGN
Regeneron Pharmaceuticals IncVltgmltsNxyzm$106.1 Bil
MRNA
Moderna IncBfczwbcpGxp$42.3 Bil
ARGX
argenx SE ADRMyyzvyrmFkwlg$23.7 Bil
BNTX
BioNTech SE ADRPmcgdppvWpqld$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncLjrfvgmXhdfmm$19.4 Bil
BMRN
Biomarin Pharmaceutical IncCljqqdbyfTrqlf$16.7 Bil
RPRX
Royalty Pharma PLC Class AMzmkrmvmlHckpzqb$13.6 Bil
INCY
Incyte CorpGbwjfkbcWfsqgmr$12.8 Bil

Sponsor Center